Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension-Reference-Cited by-同舟云学术

Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension

Published:1993-02 Issue:1 Volume:7 Page:133-138
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Chen Ming-Fong,Chen Cyeng-Chi,Chen Wen-Jone,Wu Chau-Chung,Liau Chiau-Suong,Lee Yuan-Teh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00878322.pdf

Reference26 articles.

1. Weinberger MH. Can essential hypertension be subclassified with respect to mechanisms?Hypertension 1991;18(Suppl I):182?186.

2. Bianchi G, Ferrari P, Barber BR. Lessons from experimental genetic hypertension. In: Laragh JH, Brenner BM, eds.Hypertension. New York: Raven Press, 1990:901?922.

3. Ruegg UT, Hof RP. Pharmacology of the calcium antagonist isradipine.Drugs 1990;40(Suppl 2):3?9.

4. Fitton A, Benfield P. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular diseases.Drugs 1990;40:31?74.

5. De Keyser P, Bouve J, Clement D, et al. Isradipine in essential hypertension: The Belgian general practitioners' study.Am J Med 1989;86(Suppl 4A):103?109.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethnic specific recommendations in clinical practice guidelines: a first exploratory comparison between guidelines from the USA, Canada, the UK, and the Netherlands;Quality and Safety in Health Care;2003-10-01

2. Isradipine;Drugs;1995-04